Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1969 2
1971 4
1973 2
1974 3
1975 2
1976 1
1977 2
1979 5
1980 4
1981 1
1982 6
1983 3
1984 3
1985 3
1986 5
1987 3
1988 5
1989 1
1990 6
1991 1
1992 2
1995 1
1996 1
1998 1
1999 1
2005 1
2007 1
2008 2
2009 1
2010 8
2011 4
2012 10
2013 5
2014 5
2015 3
2016 3
2017 6
2018 8
2019 9
2020 7
2021 9
2022 13
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Review and Consensus on Pharmacogenomic Testing in Psychiatry.
Bousman CA, Bengesser SA, Aitchison KJ, Amare AT, Aschauer H, Baune BT, Asl BB, Bishop JR, Burmeister M, Chaumette B, Chen LS, Cordner ZA, Deckert J, Degenhardt F, DeLisi LE, Folkersen L, Kennedy JL, Klein TE, McClay JL, McMahon FJ, Musil R, Saccone NL, Sangkuhl K, Stowe RM, Tan EC, Tiwari AK, Zai CC, Zai G, Zhang J, Gaedigk A, Müller DJ. Bousman CA, et al. Among authors: musil r. Pharmacopsychiatry. 2021 Jan;54(1):5-17. doi: 10.1055/a-1288-1061. Epub 2020 Nov 4. Pharmacopsychiatry. 2021. PMID: 33147643
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.
Müller-Vahl KR, Pisarenko A, Szejko N, Haas M, Fremer C, Jakubovski E, Musil R, Münchau A, Neuner I, Huys D, van Elst LT, Schröder C, Ringlstetter R, Koch A, Jenz EB, Großhennig A. Müller-Vahl KR, et al. Among authors: musil r. Psychiatry Res. 2023 May;323:115135. doi: 10.1016/j.psychres.2023.115135. Epub 2023 Feb 28. Psychiatry Res. 2023. PMID: 36878177 Free article. Clinical Trial.
[Patients with tics].
Schnell JML, Weidinger E, Musil R. Schnell JML, et al. Among authors: musil r. MMW Fortschr Med. 2018 Sep;160(15):47-50. doi: 10.1007/s15006-018-0886-1. MMW Fortschr Med. 2018. PMID: 30206848 Review. German. No abstract available.
[Long-term treatment of bipolar disorder].
Berger M, Musil R, Seemüller F. Berger M, et al. Among authors: musil r. Fortschr Neurol Psychiatr. 2014 Jun;82(6):346-58; quiz 359-60. doi: 10.1055/s-0034-1366575. Epub 2014 Jun 5. Fortschr Neurol Psychiatr. 2014. PMID: 24901318 Review. German. No abstract available.
[Patients with tic disorders: widely known, yet underserved].
Schnell JML, Weidinger E, Musil R. Schnell JML, et al. Among authors: musil r. Fortschr Neurol Psychiatr. 2019 Oct;87(10):577-589. doi: 10.1055/a-0996-0944. Epub 2019 Oct 18. Fortschr Neurol Psychiatr. 2019. PMID: 31627240 Review. German.
Weight gain and antipsychotics: a drug safety review.
Musil R, Obermeier M, Russ P, Hamerle M. Musil R, et al. Expert Opin Drug Saf. 2015 Jan;14(1):73-96. doi: 10.1517/14740338.2015.974549. Epub 2014 Nov 15. Expert Opin Drug Saf. 2015. PMID: 25400109 Review.
Deconstructing depression by machine learning: the POKAL-PSY study.
Eder J, Pfeiffer L, Wichert SP, Keeser B, Simon MS, Popovic D, Glocker C, Brunoni AR, Schneider A, Gensichen J, Schmitt A, Musil R, Falkai P; POKAL Group. Eder J, et al. Among authors: musil r. Eur Arch Psychiatry Clin Neurosci. 2023 Dec 13. doi: 10.1007/s00406-023-01720-9. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 38091084
162 results